Michelle Chintanaphol

University of Tennessee Health Science Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection”.

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection

Journal of Virus Eradication(2020)10.1016/j.jve.2020.100004

N/A

0DataRank · unranked

44 citations

Jintanat Ananworanich, Amélie Pagliuzza, Ajantha Rhodes, Nittaya Phanuphak, Lydie Trautmann +24 more

Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy

Clinical Infectious Diseases(2021)10.1093/cid/ciab484

N/A

0DataRank · unranked

36 citations

Rachela Calvi, Mika Naganawa, Takuya Toyonaga, Shelli Farhadian, Michelle Chintanaphol +8 more

Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling

Reviews in Cardiovascular Medicine(2022)10.31083/j.rcm2303108

N/A

0DataRank · unranked

42 citations

Buyan‐Ochir Orgil, Neely R. Alberson, Jeffrey A. Towbin, Enkhsaikhan Purevjav, Michelle Chintanaphol